New Zealand markets closed

Autolus Therapeutics plc (AUTL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.93000.0000 (0.00%)
At close: 04:00PM EDT
4.0400 +0.11 (+2.80%)
After hours: 07:24PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.05B
Enterprise value 858.49M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)402.59
Price/book (mrq)9.38
Enterprise value/revenue 505.59
Enterprise value/EBITDA 0.24

Trading information

Stock price history

Beta (5Y monthly) 2.03
52-week change 342.91%
S&P500 52-week change 326.44%
52-week high 37.4500
52-week low 32.0100
50-day moving average 35.0523
200-day moving average 34.4909

Share statistics

Avg vol (3-month) 31.55M
Avg vol (10-day) 31.44M
Shares outstanding 5265.93M
Implied shares outstanding 6265.93M
Float 891.18M
% held by insiders 118.04%
% held by institutions 163.57%
Shares short (30 Apr 2024) 43.52M
Short ratio (30 Apr 2024) 42.11
Short % of float (30 Apr 2024) 41.79%
Short % of shares outstanding (30 Apr 2024) 41.32%
Shares short (prior month 28 Mar 2024) 44.17M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-10,337.34%

Management effectiveness

Return on assets (ttm)-25.35%
Return on equity (ttm)-101.61%

Income statement

Revenue (ttm)1.7M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)N/A
EBITDA -168.96M
Net income avi to common (ttm)-208.38M
Diluted EPS (ttm)-1.2000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)239.57M
Total cash per share (mrq)0.9
Total debt (mrq)223.87M
Total debt/equity (mrq)200.82%
Current ratio (mrq)6.15
Book value per share (mrq)0.64

Cash flow statement

Operating cash flow (ttm)-145.59M
Levered free cash flow (ttm)-125.13M